Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

José Laurent Cohen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5077-6726; OpenAlex author ID A5012996331. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 7

  1. The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy. Co-author DOI 10.1016/j.ejphar.2025.177310↗
  2. Corrigendum to "The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarc… Co-author DOI 10.1016/j.ejphar.2025.177383↗
  3. Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines. Co-author DOI 10.1002/pmic.202400058↗
  4. TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion. Last author DOI 10.1136/jitc-2024-008898↗
  5. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Co-author DOI 10.3390/cancers14174265↗
  6. Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265. Co-author DOI 10.3390/cancers14246160↗
  7. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13122986↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ilaria Cascone · 7 shared papers, 2021–2025 · strength 1.17
  2. Benedetta Ferrara · 3 shared papers, 2024–2025 · strength 0.66
  3. Anaïs Debesset · 4 shared papers, 2021–2024 · strength 0.51
  4. Matteo Ponzo · 4 shared papers, 2021–2024 · strength 0.51
  5. Fabrice Raineri · 2 shared papers, 2025 · strength 0.47
  6. Sabrina Belbekhouche · 2 shared papers, 2025 · strength 0.47
  7. Mounira Chalabi‐Dchar · 3 shared papers, 2021–2022 · strength 0.34
  8. Fabio Raineri · 3 shared papers, 2021–2022 · strength 0.34
  9. Philippe Bouvet · 3 shared papers, 2021–2022 · strength 0.34
  10. Rémy Nicolle · 2 shared papers, 2022 · strength 0.23
  11. Corinne Bousquet · 2 shared papers, 2022 · strength 0.23
  12. Christophe Tournigand · 2 shared papers, 2022 · strength 0.23
  13. Jerome F. Cros · 1 shared paper, 2021 · strength 0.11
  14. Anne Couvelard Benveniste · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.